Early treatment with the ACE inhibitor lisinopril in diabetic patients with acute MI is associated with a decreased 6-week mortality. This beneficial effect supports a widespread and early use of ACE inhibitors in diabetic patients with acute MI. The burden of mortality plus morbidity for ventricular dysfunction in diabetics remains clinically important and warrants further testing of novel therapeutic approaches.
Gianni Casella, Stefano Savonitto, Francesco Chiarella, Lucio Gonzini, Di Chiara A, Leonardo Bolognese, De Servi S, Cesare Greco, P. Zonzin, Stefano Coccolini, Aldo Maggioni, Alessandro Boccanelli, Blitz Study Investigators
Discussion(0)
No comments yet. Be the first to comment.